Eversept Partners, LP Logic Bio Therapeutics, Inc. Transaction History

Eversept Partners, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$0.61 - $2.49 $177,571 - $724,841	-291,101 Closed	0 $0
Q4 2021 Nov 08, 2023	SELL	$2.2 - $4.53 $129,399 - $266,445	-58,818 Reduced 16.81%	291,101 $672,000
Q4 2021 Feb 14, 2022	SELL	$2.2 - $4.53 $129,399 - $266,445	-58,818 Reduced 16.81%	291,101 $672,000
Q3 2021 Nov 08, 2023	BUY	$3.85 - $5.09 $1.35 Million - $1.78 Million	349,919 New	349,919 $1.6 Million
Q3 2021 Nov 15, 2021	BUY	$3.85 - $5.09 $1.35 Million - $1.78 Million	349,919 New	349,919 $1.6 Million

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.